Ontology highlight
ABSTRACT: Background
Identifying individuals before the onset of overt symptoms is key in the prevention of Alzheimer's disease (AD).Objectives
Investigate the use of miRNA as early blood-biomarker of cognitive decline in older adults.Design
Cross-sectional.Setting
Two observational cohorts (CHARIOT-PRO, Alzheimer's Disease Neuroimaging Initiative (ADNI)).Participants
830 individuals without overt clinical symptoms from CHARIOT-PRO and 812 individuals from ADNI.Measurements
qPCR analysis of a prioritised set of 38 miRNAs in the blood of individuals from CHARIOT-PRO, followed by a brain-specific functional enrichment analysis for the significant miRNAs. In ADNI, genetic association analysis for polymorphisms within the significant miRNAs' genes and CSF
SUBMITTER: Sadlon A
PROVIDER: S-EPMC10994991 | biostudies-literature | 2024
REPOSITORIES: biostudies-literature